Adams B, Moghaddam B (2001) Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex. Biol Psychiatry 50:750–757

Article  CAS  PubMed  Google Scholar 

Aghajanian GK, Marek GJ (1999a) Serotonin and hallucinogens. Neuropsychopharmacology 21:16S–23S

Article  CAS  PubMed  Google Scholar 

Aghajanian GK, Marek GJ (1999b) Serotonin-glutamate interactions: new target for antipsychotic drugs. Neuropsychopharmacology 21:S122–S133

CAS  Google Scholar 

Aghajanian GK, Marek GJ (2000) Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Res Rev 31:302–312

CAS  PubMed  Google Scholar 

Anis NA, Berry SC, Burton NR, Lodge D (1983) The dissociative anesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurons by N-methyl-aspartate. Br J Pharmacol 79:565–575

CAS  PubMed  Google Scholar 

Ator NA (1990) Drug discrimination and drug stimulus generalization with anxiolytics. Drug Dev Res 20:189–204

CAS  Google Scholar 

Balster RL (1990) Perception of drug effects. In: Berkeley MA, Stebbens WG (eds) Comparative perception (vol 1). Wiley, New York, pp 127–154

Balster RL, Willetts J (1996) Phencyclidine: a drug of abuse and a tool for neuroscience research. In: Shuster CR, Kuhar MJ (eds) Pharmacological aspects of drug dependence: towards an integrated neurobehavioral approach. Springer, Berlin, pp 233–262

Brauer LH, Goudie AJ, deWit H (1997) Dopamine ligands and the stimulus effects of amphetamine: animal models versus human laboratory data. Psychopharmacology 130:2–13

Article  CAS  PubMed  Google Scholar 

Breese, GR, Knapp, DJ, Moy, SS (2002) Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness. Neurosci Biobehav Rev 26:441–455

Article  CAS  PubMed  Google Scholar 

Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson ML (2001) Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 41:237–260

Article  CAS  PubMed  Google Scholar 

Cartmell J, Schoepp DD (2000) Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem 75:899–907

Google Scholar 

Cartmell J, Monn JA, Schoepp DD (1999) The metabotropic glutamate 2/3 receptor agonists LY354740 and Ly379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats. J Pharmacol Exp Ther 291:161–170

CAS  PubMed  Google Scholar 

Cartmell J, Monn JA, Schoepp DD (2000) Attenuation of specific PCP-evoked behaviors by the potent mGlu_2/3 receptor agonist, LY379268, and comparison with the atypical antipsychotic, clozapine. Psychopharmacology 148:423–429

Article  CAS  PubMed  Google Scholar 

Compton AD, Slemmer JE, Drew MR, Hyman JM, Golden KM, Balster RL, Wiley JL (2001) Combinations of clozapine and phencyclidine: effects on drug discrimination and behavioral inhibition in rats. Neuropharmacology 40:289–297

Article  CAS  PubMed  Google Scholar 

Conn PJ, Pin J-P (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37:205–237

CAS  PubMed  Google Scholar 

Corbett R, Zhou L, Sorensen SM, Mondadori C (1999) Animal models of negative symptoms: M100907 antagonizes PCP-induced immobility in a forced swim test in mice. Neuropsychopharmacology 21:S211–S218

Article  CAS  Google Scholar 

Dall’Olio R, Gaggi R, Bonfante V, Gandolfi O (1999) The non-competitive NMDA receptor blocker dizocilpine potentiates serotonergic function. Behav Pharmacol 10:63–71

CAS  PubMed  Google Scholar 

Fiorella D, Helsley SE, Rabin RA, Winter JC (1995a) The interactions of typical and atypical antipsychotics with the (−)-DOM discriminative stimulus. Neuropharmacology 34:1297–1303

Article  CAS  PubMed  Google Scholar 

Fiorella D, Palumbo PA, Rabin RA, Winter JC (1995b) The time-dependent stimulus effects of R(−)-2,5-dimethoxy-4-methamphetamine ((−)-DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents. Psychopharmacology 119:239–245

CAS  PubMed  Google Scholar 

Fiorella D, Rabin RA, Winter JC (1995c) The role of 5-HT_2A and 5-HT_2C receptors in the stimulus effects of hallucinogenic drugs I: Antagonist correlation analysis. Psychopharmacology 121:347–356

Google Scholar 

Gewirtz JC, Marek GJ (2000) Behavioral evidence for interactions between a hallucinogenic drug and group II metabotropic glutamate receptors. Neuropsychopharmacology 23:569–576

Article  CAS  PubMed  Google Scholar 

Habara T, Hamamura T, Miki M, Ohashi K, Kuroda S (2001) M100907, a selective 5-HT_2A receptor antagonist, attenuates phencyclidine-induced Fos expression in discrete regions of rat brain. Eur J Pharmacol 417:189–194

Article  CAS  PubMed  Google Scholar 

Heffter A (1897) Uber Pellote. Arch Exptl Pathol Pharmakol 40:418–425

Google Scholar 

Hirschhorn ID, Winter JC (1971) Mescaline and lysergic acid diethylamide (LSD) as discriminative stimuli. Psychopharmacology 22:64–71

CAS  Google Scholar 

Hofmann A (1959) Psychotomimetic drugs, chemical and pharmacological aspects. Acta Physiol Pharmacol Neerl 8:240–258

CAS  PubMed  Google Scholar 

Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301–1308

CAS  PubMed  Google Scholar 

Kapur S, Seeman P (2002) NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D₂ and serotonin 5-HT₂ receptors—implications for models of schizophrenia. Mol Pharmacol 7:837–844

Article  CAS  Google Scholar 

Keenan KP, Smith PF, Hertzog P, Soper K, Ballam GC, Clark RL (1994) The effects of overfeeding and dietary restriction on Sprague-Dawley rat survival and early pathology biomarkers of aging. Toxicol Pathol 22:300–315

CAS  PubMed  Google Scholar 

Kim HS, Park IS, Park WK (1998) NMDA receptor antagonists enhance 5-HT₂ receptor mediated behavior, head twitch response, in mice. Life Sci 63:2305–2311

Article  CAS  PubMed  Google Scholar 

Kim HS, Park IS, Lim, HK (1999) NMDA receptor antagonists enhance 5-HT₂ receptor mediated behavior, head twitch response, in PCPA-treated mice. Arch Pharm Res 22:113–118

CAS  PubMed  Google Scholar 

Klodzinska A, Bijak M, Tokarski K, Pilc A (2002) Group II mGlu receptor agonists inhibit behavioral and electrophysiological effects of DOI in mice. Pharmacol Biochem Behav 73:327–332

Article  CAS  PubMed  Google Scholar 

Koek W (1999) N-Methyl-d-aspartate antagonists and drug discrimination. Pharmacol Biochem Behav 64:275–281

Article  CAS  PubMed  Google Scholar 

Krystal JH, Belger A, D’Souza DC, Anand A, Charney DS, Aghajanian GK, Moghaddam B (1999) Therapeutic implications of the hyperglutamatergic effects of NMDA antagonists. Neuropsychopharmacology 22:S143–S157

Article  Google Scholar 

Luby ED (1981) Phencyclidine revisited. In: Domino EF (ed) PCP (phencyclidine): historical and current perspectives. NPP Books, Ann Arbor, pp 25–30

Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelly R (1959) Study of the new schizophrenomimetic drug l-sernyl. Arch Neurol Psychiatry 81:363–368

Google Scholar 

Mansbach RS, Balster RL (1991) Pharmacological specificity of the phencyclidine discriminative stimulus in rats. Pharmacol Biochem Behav 39:971–975

Article  CAS  PubMed  Google Scholar 

Marek GJ (2000) A novel approach to the identification of psychiatric drugs: serotonin-glutamate interactions in the prefrontal cortex. CNS Drug Rev 6:206–218

CAS  Google Scholar 

Marek GJ, Wright RA, Schoepp DD, Monn JA, Aghajanian GK (2000) Physiological antagonism between 5-hydroxytryptamine_2A and group II metabotropic glutamate receptors in prefrontal cortex. J Pharmacol Exp Ther 292:76–87

Google Scholar 

Martin-Ruiz R, Puig MV, Celada P, Shapiron DA, Roth BL, Mengod G, Artigas F (2001) Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors thorough a glutamate-dependent mechanism. J Neurosci 21:9856–9866

CAS  PubMed  Google Scholar 

Maurel-Remy S, Bervoets K, Millan MJ (1995) Blockade of phencyclidine-induced hyperlocomotion by clozapine and MDL 100,907 in rats reflects antagonism of 5-HT_2A receptors. Eur J Pharmacol 280:R9–R11

CAS  PubMed  Google Scholar 

Meert T, Stolerman I (1999) Drug discrimination in behavioral neuroscience. Pharmacol Biochem Behav 64:191–453

Article  CAS  Google Scholar 

Miner LAH, Backstrom JR, Sanders-Bush E, Sesack SR (2003) Ultrastructural localization of serotonin_2A receptors in the middle layers of the rat prelimbic prefrontal cortex. Neuroscience 116:107–117

Article  CAS  PubMed  Google Scholar 

Moghaddam B, Adams BW (1998) Reversal of phencylidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281:1349–1352

CAS  PubMed  Google Scholar 

Nabeshima T, Ishikawa K, Yamiguchi K, Furakawa H, Kameyama T (1984a) Phencyclidine interacts with serotonin₂ but not serotonin₁ receptor. Res Commun Subst Abuse 5:81–87

CAS  Google Scholar 

Nabeshima T, Noda Y, Ishikawa K, Furakawa, Kameyama T (1984b) Phencyclidine decreases binding capacity of serotonin₂ receptor in vitro. Res Commun Subst Abuse 5:175–186

CAS  Google Scholar 

Nabeshima T, Ishikawa K, Yamiguchi K, Furakawa H, Kameyama T (1988) Protection with phencyclidine against inactivation of 5-HT₂ receptors by sulfhydral-modifying reagents. Biochem Pharmacol 37:3277–3283

Article  CAS  PubMed  Google Scholar 

Olney JW, Farber NB (1995) NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia. Neuropsychopharmacology 13:335–345

Article  CAS  PubMed  Google Scholar 

Ossowska K, Pietraszek M, Warda J, Zajaczkowski W, Wolfarth S, Pilc A (2000) The role of glutamate receptors in antipsychotic drug action. Amino Acids 19:87–94

CAS  PubMed  Google Scholar 

Sanger DJ, Benavides J, Perrault G, Morel E, Cohen C, Joly D, Zivkovic B (1994) Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for functional significance of receptor subtypes. Neurosci Biobehav Rev 18:355–372

CAS  PubMed  Google Scholar 

Schoepp DD (2001) Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J Pharmacol Exp Ther 299:12–20

Google Scholar 

Schreiber R, Brocco M, Audinot V, Gobert A, Veiga S, Millan MJ (1995) DOI-induced head-twitches in the rat are mediated by 5-HT_2A receptors: modulation by novel 5-HT_2A/2C antagonists, D₁ antagonists, and 5-HT_1A agonists. J Pharmacol Exp Ther 273:101–112

CAS  PubMed  Google Scholar 

Schreiber R, Lowe D, Voerste A, De Vry J (2000) LY354740 affects startle responding but not sensorimotor gating or discriminative effects of phencyclidine. Eur J Pharmacol 388:R3–R4

CAS  PubMed  Google Scholar 

Schuster C, Johanson C (1988) Relationship between the discriminative stimulus properties and subjective effects of drugs In: Colpaert F, Balster R (eds) Transduction mechanisms of drug stimuli. Springer, Berlin, pp 161–175

Google Scholar 

Steinpreis RE (1996) The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis. Behav Brain Res 74:45–55

CAS  PubMed  Google Scholar 

Swanson CJ, Schoepp DD (2002) The group II metabotropic glutamate receptor agonist (−)-2-oxa-4-aminobicyclo(3.1.0)hexane-4,6-dicarboxylate (LY379268) and clozapine reverse phencyclidine-induced behaviors in monoamine-depleted rats. J Pharmacol Exp Ther 303:919–927

Article  CAS  PubMed  Google Scholar 

Swerdlow NR, Bakshi V, Geyer MA (1996) Seroquel restores sensorimotor gating in phencyclidine-treated rats. J Pharmacol Exp Ther 279:1290–1299

CAS  PubMed  Google Scholar 

Tricklebank MD, Singh L, Oles RJ, Wong EHF, Iversen SD (1987) A role for N-methyl-d-aspartic acid in the discriminative stimulus properties of phencyclidine. Eur J Pharmacol 141:497–501

Article  CAS  PubMed  Google Scholar 

Vollenweider FX (1998) Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research. Pharmacopsychiatry 31:92–103

CAS  PubMed  Google Scholar 

Winter JC (1974) Hallucinogens as discriminative stimuli. Fed Proc 33:1825–1832

CAS  PubMed  Google Scholar 

Winter JC (1978) Drug-induced stimulus control. In: Blackman DE, Sanger DJ (eds) Contemporary research in behavioral pharmacology. Plenum Press, New York, pp 209–237

Winter JC, Fiorella DJ, Timineri DM, Filipink RA, Helsley SE, Rabin RA (1999) Serotonergic receptor subtypes and hallucinogen-induced stimulus control. Pharmacol Biochem Behav 64:283–293

Article  CAS  PubMed  Google Scholar 

Winter JC, Doat M, Rabin RA (2000) Potentiation of DOM-induced stimulus control by non-competitive NMDA antagonists: a link between the glutamatergic and serotonergic hypotheses of schizophrenia. Life Sci 68:337–344

Article  CAS  PubMed  Google Scholar 

Yamada S, Harano M, Annoh N, Nakamura K (1999) Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats. Biol Psychiatry 46:832–838

CAS  PubMed  Google Scholar 

Zukin SR, Zukin RS (1979) Specific (³H)phencyclidine binding in rat central nervous system. Proc Natl Acad Sci USA 76:5372–5376

CAS  PubMed  Google Scholar